Stay updated with breaking news from Turing Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As gene sequencing, machine learning, powerful imaging, sensors, gene and cell therapies make their way out of academic labs into everyday healthcare, our approach to healthcare is changing. For the first time, not only can we pinpoint the molecular and genetic causes of disease, but we also have the technologies to access them. On the back of this, prevention and cures are becoming possible. Can we afford them?
While major pharmaceutical companies have always been derided for considering profits over the well-being of the general population, even earning the moniker of "Big Pharma" denoting a shadow organization...
The notorious former Turing Pharmaceuticals boss served a little more than half of his seven-year sentence.
Commentary As inflation rates soar toward 8 percent in the United States, many are feeling the squeeze and will ...
The patent system in pharmaceuticals incentivizes firms to game the system for monopoly profits